Drug Topics May 27, 2024
To assess the extent of FTC regulation, researchers collected data from the group’s merger and enforcement actions in a 22-year span.
From 2002 to 2022, the Federal Trade Commission (FTC) carried out an average of 1 enforcement action and 3 merger actions per year, demonstrating what researchers agreed is a weak hand for regulating competition and consolidation in the prescription drug market.1
The FTC is an independent government agency that oversees the country’s rights to consumerism and promotes competition within respective markets. In the case of the pharmaceutical industry, however, the FTC has been known to be lax in its regulation.
“The FTC historically has not played an aggressive role in overseeing the pharmaceutical market, although the question of when...
Today's Sponsors
Today's Sponsor